Table 1.

Selected published studies that reported adverse effects of remdesivir on cardiovascular system

Authors	Study design	Year	The number of COVID-19 patients with an adverse event	Follow-up time	Side effects
Grein et al	Cohort	2020	7	28 days	Hypotension, AF rhythm
Gupta et al	Case presentation	2020	2	During hospitalization	Bradycardia, Prolonged QT interval, T-wave abnormality
Michaud et al	Pharmacological study	2021	Not applicable	Not applicable	Prolonged QT interval, Torsade de point
Mulangu et al	A randomized, controlled trial	2019	1	During hospitalization	Hypotension, cardiac arrest
Wang et al	A randomized, double-blind, placebo-controlled, multicenter trial	2020	1	During hospitalization	Cardiac arrest
Gubitosa et al	Case presentation	2020	1	During hospitalization	Sinus bradycardia and QRS widening
Bistrovic et al	Pilot study	2021	10	During hospitalization	T‐wave rightward axis deviation
Rafaniello et al	Meta-analysis	2021	Twofold increased risk	During hospitalization	Adverse cardiac event
Sanchez-Codez et al	Case presentation	2021	1	During hospitalization	Sinus bradycardia
Selvaraj et al	Case presentation	2021	1	During hospitalization	Complete heart block
Barkas et al	Case presentation	2021	1	During hospitalization	Sinus bradycardia
Chow et al	Case presentation	2021	1	During hospitalization	Sinus bradycardia

AF atrial fibrillation